Lv1
90 积分 2022-06-14 加入
Efficacy and Safety of Telitacicept as an Add-on Therapy for Refractory IgA Nephropathy/ IgA Vasculitis Nephropathy in Children
17天前
已完结
Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis
19天前
已完结
TACI Ig Fusion Protein Inhibits TLR4/MyD88/NF-κB Pathway Alleviates Renal Injury in IgA Nephropathy Rats
20天前
已完结
泰它西普治疗IgA肾病的有效性及安全性研究
23天前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
25天前
已完结
Immunotherapy in autoimmune encephalitis
25天前
已完结
B cell-targeted therapies in systemic lupus erythematosus
25天前
已完结
Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy
25天前
已完结
Lupus Nephritis: Redefining the treatment goals
25天前
已完结
皖公网安备34019202002308
